Mehta P, Thummar V, Bhavsar H. Clinical outcomes of neoadjuvant dual HER2 blockade with pertuzumab/Sigrima and trastuzumab/Vivitra biosimilars: real-world evidence in HER2-positive breast cancer in India. Int J Res Med Sci [Internet]. 2026 Mar. 30 [cited 2026 Apr. 7];14(4):1584-8. Available from: https://www.msjonline.org/index.php/ijrms/article/view/16637